MicroRNA-100 is a potential molecular marker of non-small cell lung cancer and functions as a tumor suppressor by targeting polo-like kinase 1.
about
A potential role for estrogen in cigarette smoke-induced microRNA alterations and lung cancerMicroRNA-100 promotes the autophagy of hepatocellular carcinoma cells by inhibiting the expression of mTOR and IGF-1R.microRNA expression and biogenesis in cellular response to ionizing radiationA genome-wide investigation of microRNA expression identifies biologically-meaningful microRNAs that distinguish between high-risk and low-risk intraductal papillary mucinous neoplasms of the pancreasNovel candidate key drivers in the integrative network of genes, microRNAs, methylations, and copy number variations in squamous cell lung carcinoma.Role of miR-100 in the radioresistance of colorectal cancer cells.Down-regulation of microRNA-124 is correlated with tumor metastasis and poor prognosis in patients with lung cancer.Identification and characterization of tumor suppressor and oncogenic miRNAs in gastric cancer.MicroRNA 100 sensitizes luminal A breast cancer cells to paclitaxel treatment in part by targeting mTOR.Integrative transcriptome analysis identifies deregulated microRNA-transcription factor networks in lung adenocarcinoma.Prognostic significance of microRNA-100 in solid tumors: an updated meta-analysis.MicroRNA-100 is involved in shrimp immune response to white spot syndrome virus (WSSV) and Vibrio alginolyticus infection.Genetic and epigenetic silencing of mircoRNA-506-3p enhances COTL1 oncogene expression to foster non-small lung cancer progression.The role of microRNAs in lung cancer progression.Battle of the eternal rivals: restoring functional p53 and inhibiting Polo-like kinase 1 as cancer therapy.MicroRNAs in adrenal tumors: relevance for pathogenesis, diagnosis, and therapy.Potential role of miR-100 in cancer diagnosis, prognosis, and therapy.Regulation of PLK1 through competition between hnRNPK, miR-149-3p and miR-193b-5p.The clinical and prognostic value of polo-like kinase 1 in lung squamous cell carcinoma patients: immunohistochemical analysis.MiR-100 Inhibits Osteosarcoma Cell Proliferation, Migration, and Invasion and Enhances Chemosensitivity by Targeting IGFIR.MicroRNA-100 inhibits osteosarcoma cell proliferation by targeting Cyr61.MicroRNA-128 promotes proliferation in osteosarcoma cells by downregulating PTEN.A 3'UTR polymorphism modulates mRNA stability of the oncogene and drug target Polo-like Kinase 1.Overexpression of miR-100 inhibits cancer growth, migration, and chemosensitivity in human NSCLC cells through fibroblast growth factor receptor 3.Pooling-analysis for diagnostic and prognostic value of MiRNA-100 in various cancers.microRNA-100 targets SMRT/NCOR2, reduces proliferation, and improves survival in glioblastoma animal models.Refute the conclusion made by Jie et al. in "prognostic role of microRNA-100 in various carcinomas: evidence from six studies".Inactivation of miR-100 combined with arsenic treatment enhances the malignant transformation of BEAS-2B cells via stimulating epithelial -mesenchymal transition.Downregulation of microRNA-100 correlates with tumor progression and poor prognosis in hepatocellular carcinoma.DNA-PKcs associates with PLK1 and is involved in proper chromosome segregation and cytokinesis.Prognostic role of microRNA-100 in various carcinomas: evidence from six studies.
P2860
Q26740327-62E736E0-EB84-4A4D-8201-4D0BD32CF8C1Q34227658-08A757FD-E044-4618-8E23-7ECB846328E3Q34269240-EBFCA719-5C38-4C1F-9B6E-1E7A2C09183EQ34994302-B82534BA-C024-4DAB-A912-5D1BE0AC0DF7Q35156742-5917C40A-9D70-482D-86D9-7E359AB9B3BDQ35402735-4DDCB915-FF76-4695-925C-8EDB373AE6B8Q35406692-E51BE616-0B94-4FAC-B80B-13E4A6AD07EAQ35803918-233E5382-531A-43C6-B833-AD27924882F7Q36905747-0355691D-426A-43E5-9E9F-3A9A3A9A02FCQ37301705-F57E5B74-8020-482D-A0C6-726C398761D5Q37610478-7FBC630E-4ACF-4B46-B2C7-9837101E23B3Q37633283-797F4965-0935-4D33-8AB3-BE4B1C2AA741Q37702331-17875655-1717-4B7E-91EF-32A1502DF50EQ38127375-6AA1AC21-A7AB-420A-851D-D93E0752EEC0Q38129174-D2BB8BB3-3970-4E2D-B7DE-5507DF43B75AQ38258284-B991D655-65D7-4769-B25B-ADE3B67DAAD2Q38367693-187C6DEE-6641-4DE2-934B-D450D8D0E00AQ38657693-FF2B2978-D83A-4899-9C83-7F2F442562ADQ38671515-F7E9D7B9-A14D-4A3F-821E-B37B7F7B0F96Q38970929-9311C719-57CF-48BF-A133-4905B4749F5AQ39045467-E8E9425C-7A4B-4724-B4EA-C280E03F019EQ39077654-5710F052-BB2F-483B-ABF9-C63329A544B3Q39599711-DF5FB9E8-2E70-413D-9B51-B6DA410B011EQ40599368-53EFC9A4-BC78-4F83-A429-660CD4B2761AQ42365364-86B1220F-D623-4D7D-A266-97D8B73AA6C7Q42906818-87FDAA85-29D1-4901-A755-DD5B2CA64633Q43579814-CC642010-D4ED-473A-9285-F14470881626Q47125575-27C0DF76-A319-4BA9-8B5D-C86506AF2554Q48031390-5E86992E-7B1D-4B35-9A2D-9E82AF8F2930Q53090357-A60C23EF-973D-4993-95A8-F3D7ABBA9B15Q54563939-402FF15A-50E9-44EB-8A99-36AF9E185F25
P2860
MicroRNA-100 is a potential molecular marker of non-small cell lung cancer and functions as a tumor suppressor by targeting polo-like kinase 1.
description
2012 nî lūn-bûn
@nan
2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
MicroRNA-100 is a potential mo ...... targeting polo-like kinase 1.
@ast
MicroRNA-100 is a potential mo ...... targeting polo-like kinase 1.
@en
MicroRNA-100 is a potential mo ...... targeting polo-like kinase 1.
@nl
type
label
MicroRNA-100 is a potential mo ...... targeting polo-like kinase 1.
@ast
MicroRNA-100 is a potential mo ...... targeting polo-like kinase 1.
@en
MicroRNA-100 is a potential mo ...... targeting polo-like kinase 1.
@nl
prefLabel
MicroRNA-100 is a potential mo ...... targeting polo-like kinase 1.
@ast
MicroRNA-100 is a potential mo ...... targeting polo-like kinase 1.
@en
MicroRNA-100 is a potential mo ...... targeting polo-like kinase 1.
@nl
P2093
P2860
P356
P1433
P1476
MicroRNA-100 is a potential mo ...... targeting polo-like kinase 1.
@en
P2093
P2860
P2888
P356
10.1186/1471-2407-12-519
P407
P577
2012-11-14T00:00:00Z
P5875
P6179
1045522576